Yoni Iger - Venus Concept Head Affairs
| VERO Stock | USD 0.33 0.04 13.79% |
Executive
Yoni Iger is Head Affairs of Venus Concept
| Age | 64 |
| Address | 235 Yorkland Boulevard, Toronto, ON, Canada, M2J 4Y8 |
| Phone | 877 848 8430 |
| Web | https://www.venus.ai |
Yoni Iger Latest Insider Activity
Tracking and analyzing the buying and selling activities of Yoni Iger against Venus Concept stock is an integral part of due diligence when investing in Venus Concept. Yoni Iger insider activity provides valuable insight into whether Venus Concept is net buyers or sellers over its current business cycle. Note, Venus Concept insiders must abide by specific rules, including filing SEC forms every time they buy or sell Venus Concept'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Yoni Iger over three months ago Insider Trading |
Venus Concept Management Efficiency
The company has return on total asset (ROA) of (0.1866) % which means that it has lost $0.1866 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.6354) %, meaning that it created substantial loss on money invested by shareholders. Venus Concept's management efficiency ratios could be used to measure how well Venus Concept manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of November 2024, Return On Equity is likely to grow to 2.79, while Return On Tangible Assets are likely to drop (0.46). At this time, Venus Concept's Total Assets are very stable compared to the past year. As of the 22nd of November 2024, Non Current Assets Total is likely to grow to about 31.5 M, while Non Currrent Assets Other are likely to drop about 490.1 K.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Harold Tamayo | Axogen Inc | N/A | |
| Jennifer Boyer | Inogen Inc | N/A | |
| Jeremy JD | Sight Sciences | 54 | |
| FACC MBA | Nuwellis | N/A | |
| Isabelle Billet | Axogen Inc | 62 | |
| Robert John | CVRx Inc | N/A | |
| Indranil Dey | Bluejay Diagnostics | 61 | |
| James Chase | Anika Therapeutics | N/A | |
| Ivan Bilic | Establishment Labs Holdings | N/A | |
| Lawrence Lin | Ainos Inc | 55 | |
| Gordon Weber | SurModics | 61 | |
| Dan Yarbrough | Orthofix Medical | N/A | |
| Jennifer Englund | CVRx Inc | N/A | |
| HsinLiang Lee | Ainos Inc | 53 | |
| Jill Mason | Orthofix Medical | N/A | |
| Suzanne Armstrong | Orthofix Medical | N/A | |
| Maria Martinez | Axogen Inc | 56 | |
| Doris Quackenbush | Axogen Inc | N/A | |
| Julie Andrews | Orthofix Medical | 53 | |
| Grgoire Ramade | Inogen Inc | 54 | |
| Lucas Vitale | Orthofix Medical | 47 | |
Management Performance
| Return On Equity | -4.64 | ||||
| Return On Asset | -0.19 |
Venus Concept Leadership Team
Elected by the shareholders, the Venus Concept's board of directors comprises two types of representatives: Venus Concept inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Venus. The board's role is to monitor Venus Concept's management team and ensure that shareholders' interests are well served. Venus Concept's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Venus Concept's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anat Kotler, Head Management | ||
| Anna Georgiadis, Chief Officer | ||
| Jason Raser, Head USA | ||
| Hemanth CFA, President COO | ||
| Rajiv Silva, CEO Director | ||
| Kenji Shimizu, Interim Officer | ||
| Ross Portaro, Executive Marketing | ||
| Michael Mandarello, General Secretary | ||
| Joyce Morris, Head Canada | ||
| Ognjen Petrovic, Robotics, RD | ||
| Soren Sinay, Chief Officer | ||
| Yoni Iger, Head Affairs | ||
| Domenic Penna, Chief Officer | ||
| William McGrail, Executive Compliance |
Venus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Venus Concept a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -4.64 | ||||
| Return On Asset | -0.19 | ||||
| Profit Margin | (0.72) % | ||||
| Operating Margin | (0.34) % | ||||
| Current Valuation | 35.97 M | ||||
| Shares Outstanding | 7.26 M | ||||
| Shares Owned By Insiders | 6.07 % | ||||
| Shares Owned By Institutions | 27.03 % | ||||
| Number Of Shares Shorted | 1.45 M | ||||
| Price To Book | 0.21 X |
Pair Trading with Venus Concept
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Venus Concept position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Venus Concept will appreciate offsetting losses from the drop in the long position's value.Moving against Venus Stock
| 0.69 | VMD | Viemed Healthcare | PairCorr |
| 0.55 | DOCS | Doximity | PairCorr |
| 0.54 | FOXO | FOXO Technologies | PairCorr |
| 0.5 | ITGR | Integer Holdings Corp | PairCorr |
The ability to find closely correlated positions to Venus Concept could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Venus Concept when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Venus Concept - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Venus Concept to buy it.
The correlation of Venus Concept is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Venus Concept moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Venus Concept moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Venus Concept can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Venus Concept. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Venus Stock, please use our How to Invest in Venus Concept guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Venus Concept. If investors know Venus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Venus Concept listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.97) | Revenue Per Share 11.915 | Quarterly Revenue Growth (0.17) | Return On Assets (0.19) | Return On Equity (4.64) |
The market value of Venus Concept is measured differently than its book value, which is the value of Venus that is recorded on the company's balance sheet. Investors also form their own opinion of Venus Concept's value that differs from its market value or its book value, called intrinsic value, which is Venus Concept's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Venus Concept's market value can be influenced by many factors that don't directly affect Venus Concept's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Venus Concept's value and its price as these two are different measures arrived at by different means. Investors typically determine if Venus Concept is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Venus Concept's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.